Enhancement of the oral bioavailability of isopropoxy benzene guanidine though complexation with hydroxypropyl-β-cyclodextrin
Isopropoxy benzene guanidine (IBG) is a novel substituted benzene guanidine analogue with antibacterial activity against multidrug-resistant bacteria. However, the bioavailability of IBG is not optimal due to its finite aqueous solubility, thus hampering its potential therapeutic exploitation. In th...
Main Authors: | Yixing Lu, Liuye Yang, Wanying Zhang, Shiting Xie, Feifei Zhao, Xianfeng Peng, Zonghua Qin, Dongping Zeng, Zhenling Zeng |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/10717544.2022.2118400 |
Similar Items
-
Pharmacokinetics and pharmacodynamics of isopropoxy benzene guanidine against Clostridium perfringens in an intestinal infection model
by: Yixing Lu, et al.
Published: (2022-09-01) -
Antibacterial activity of isopropoxy benzene guanidine against Riemerella anatipestifer
by: Yixing Lu, et al.
Published: (2024-02-01) -
Isopropoxy Benzene Guanidine Kills Staphylococcus aureus Without Detectable Resistance
by: Xiufeng Zhang, et al.
Published: (2021-02-01) -
Pharmacokinetics and Pharmacodynamics of Colistin Combined With Isopropoxy Benzene Guanidine Against mcr-1-Positive Salmonella in an Intestinal Infection Model
by: Lingli Kong, et al.
Published: (2022-05-01) -
Metabolite Identification of Isopropoxy Benzene Guanidine in Rat Liver Microsomes by Using UHPLC-Q-TOF-MS/MS
by: Yixing Lu, et al.
Published: (2023-04-01)